StockBee wrote:Recently the FDA has been green-lighting research with psilocybin. From what I have read, this research has had some pretty positive results with addiction, stress, and PTSD. Do you think that if psilocybin gets full FDA approval that we could see a bullish trend in the medical sector in the US? Are you already looking or watching companies involved in this sort of research?
Cheers
My nephew in law goes to Wales every year to have his annual psilocybin "fix". Like all the hallucinogens, not addictive.
The problem as an investment proposition is that if you can pick them for free (and long may be that the case), how does the business make money. Doubtless a company will make all kinds of fluffy promises about reliable consistent doses but even assuming they could, why bother when the stuff is free? Which reminds me I need to get an identification course from my nephew in law.
Certainly there seems to be increasing recognition that hallucinogens are pretty effective at relieving/curing depression.
